Pneumocystis Pneumonia: Clinical Trials

1 trial for Pneumocystis Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Pneumocystis Pneumonia: new trials by email Literature Review of Pneumocystis Pneumonia trials Research Report on Pneumocystis Pneumonia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia
Caspofungin Acetate 50 MG, Physiologic saline - Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection
Phase 1 / Phase 2RecruitingUniversity Hospital, Tours1002025-12-022026-10-09

Narrower conditions

Lung Diseases, Interstitial (1)  ·  Pneumocystis Infections (1)  ·  Pneumonia, Pneumocystis (1)  ·  Respiratory Aspiration (1)

Broader conditions

Bacterial Infections and Mycoses (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Fungal (1)  ·  Mycoses (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Interventions

Caspofungin (1)

Sponsors

University Hospital, Tours (1)

Countries

France (1)

Results publications

PMID 16304338, PMID 18046534, PMID 20946413, PMID 22548840, PMID 23940606, PMID 26935726, PMID 30776290, PMID 31548210, PMID 31633150, PMID 32194238, PMID 41151592, PMID 9872631

NIH funding

2023 (1)